Literature DB >> 18411249

Binding of ATP to UAP56 is necessary for mRNA export.

Krishna P Kota1, Stefan R Wagner, Elvira Huerta, Jean M Underwood, Jeffrey A Nickerson.   

Abstract

The major-histocompatibility-complex protein UAP56 (BAT1) is a DEAD-box helicase that is deposited on mRNA during splicing. UAP56 is retained on spliced mRNA in an exon junction complex (EJC) or, alternatively, with the TREX complex at the 5' end, where it might facilitate the export of the spliced mRNA to the cytoplasm. Using confocal microscopy, UAP56 was found to be concentrated in RNA-splicing speckled domains of nuclei but was also enriched in adjacent nuclear regions, sites at which most mRNA transcription and splicing occur. At speckled domains, UAP56 was in complexes with the RNA-splicing and -export protein SRm160, and, as measured by FRAP, was in a dynamic binding equilibrium. The application of an in vitro FRAP assay, in which fluorescent nuclear proteins are photobleached in digitonin-extracted cells, revealed that the equilibrium binding of UAP56 in complexes at speckled domains was directly regulated by ATP binding. This was confirmed using a point mutant of UAP56 that did not bind ATP. Point mutation of UAP56 to eliminate ATP binding did not affect RNA splicing, but strongly inhibited the export of mRNA to the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18411249     DOI: 10.1242/jcs.021055

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  34 in total

1.  UAP56 is an important regulator of protein synthesis and growth in cardiomyocytes.

Authors:  Abha Sahni; Nadan Wang; Jeffrey D Alexis
Journal:  Biochem Biophys Res Commun       Date:  2010-01-29       Impact factor: 3.575

2.  Mutations in DNA binding and transactivation domains affect the dynamics of parvovirus NS1 protein.

Authors:  Einari A Niskanen; Olli Kalliolinna; Teemu O Ihalainen; Milla Häkkinen; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

3.  The Ultrastructural Signature of Human Embryonic Stem Cells.

Authors:  Jean M Underwood; Klaus A Becker; Gary S Stein; Jeffrey A Nickerson
Journal:  J Cell Biochem       Date:  2016-12-29       Impact factor: 4.429

Review 4.  The nuclear export of circular RNAs is primarily defined by their length.

Authors:  Zhengguo Li; Michael G Kearse; Chuan Huang
Journal:  RNA Biol       Date:  2018-12-17       Impact factor: 4.652

5.  UAP56 is a novel interacting partner of Bcr in regulating vascular smooth muscle cell DNA synthesis.

Authors:  Abha Sahni; Nadan Wang; Jeffrey D Alexis
Journal:  Biochem Biophys Res Commun       Date:  2012-03-13       Impact factor: 3.575

Review 6.  RNA helicases in splicing.

Authors:  Olivier Cordin; Jean D Beggs
Journal:  RNA Biol       Date:  2012-12-10       Impact factor: 4.652

7.  Effect of ATP binding and hydrolysis on dynamics of canine parvovirus NS1.

Authors:  Einari A Niskanen; Teemu O Ihalainen; Olli Kalliolinna; Milla M Häkkinen; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

8.  Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49.

Authors:  Christian Wisskirchen; Thomas H Ludersdorfer; Dominik A Müller; Eva Moritz; Jovan Pavlovic
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

9.  UAP56 is an important mediator of angiotensin II/platelet derived growth factor induced vascular smooth muscle cell DNA synthesis and proliferation.

Authors:  Abha Sahni; Nadan Wang; Jeffrey Alexis
Journal:  Biochem Biophys Res Commun       Date:  2012-12-12       Impact factor: 3.575

10.  The closely related RNA helicases, UAP56 and URH49, preferentially form distinct mRNA export machineries and coordinately regulate mitotic progression.

Authors:  Tomohiro Yamazaki; Naoko Fujiwara; Hiroko Yukinaga; Miki Ebisuya; Takuya Shiki; Tomoya Kurihara; Noriyuki Kioka; Taiho Kambe; Masaya Nagao; Eisuke Nishida; Seiji Masuda
Journal:  Mol Biol Cell       Date:  2010-06-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.